MBL77 FUNDAMENTALS EXPLAINED

mutations given The truth that, as described under, CLL therapy is based within the existence or absence of those mutations. The present consensus is, aside from clonal mutations, subclonal mutations that has a variant allelic frequency starting from five to 10% (and therefore below the edge of detection by standard molecular procedures) is also no